Efficacy, Safety and Tolerability Study of TAK-583 in Subjects With Postherpetic Neuralgia

Status:
Completed

Trial end date:
2008-02-01

Target enrollment:

Participant gender:

The purpose of this study is to evaluate the efficacy of TAK-583, once daily (QD), in relieving pain in subjects with postherpetic neuralgia.

Phase 2/Phase 3

Takeda